ÂÜÀòÂÒÂ×

Jingfang Ju is a Professor at Stony Brook University, a position held since August 2008, and Co-Founder of Curamir Therapeutics, Inc. since September 2019. Prior to these roles, Jingfang Ju served as the Head of Cancer Genomics and Assistant Professor at Mitchell Cancer Institute from January 2004 to August 2008, and as a Senior Scientist at CuraGen Corporation from January 2000 to January 2004. Jingfang Ju earned a Post-Doctoral degree in Pharmacology from Yale School of Medicine (1996-1999), a Ph.D. in Biochemistry/Molecular Biology from the University of Southern California (1992-1996), and a Bachelor of Science in Engineering from Northeastern University, P.R. China (1985-1989).